Original articles
Tumour pseudoprogression during nivolumab immunotherapy for lung cancer
Pseudoprogresión tumoral en el tratamiento inmunoterápico con nivolumab en el cáncer de pulmón
a Servicio de Radiodiagnóstico, UDIAT Centre Diagnòstic, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació ParcTaulí (I3PT), Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain
b Servicio de Oncología, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT), Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain
Read
2352
Timeswas read the article
202
Total PDF
2150
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 25 | 16 | 41 |
| 2025 11 | 0 | 62 | 62 |
| 2025 10 | 178 | 36 | 214 |
| 2025 9 | 159 | 22 | 181 |
| 2025 8 | 126 | 2 | 128 |
| 2025 7 | 123 | 1 | 124 |
| 2025 6 | 173 | 2 | 175 |
| 2025 5 | 222 | 1 | 223 |
| 2025 4 | 144 | 10 | 154 |
| 2025 3 | 85 | 2 | 87 |
| 2025 2 | 72 | 0 | 72 |
| 2025 1 | 56 | 4 | 60 |
| 2024 12 | 57 | 4 | 61 |
| 2024 11 | 32 | 3 | 35 |
| 2024 10 | 28 | 5 | 33 |
| 2024 9 | 24 | 0 | 24 |
| 2024 8 | 27 | 1 | 28 |
| 2024 7 | 27 | 3 | 30 |
| 2024 6 | 10 | 0 | 10 |
| 2024 5 | 14 | 0 | 14 |
| 2024 4 | 35 | 3 | 38 |
| 2024 3 | 29 | 4 | 33 |
| 2024 2 | 43 | 2 | 45 |
| 2024 1 | 42 | 0 | 42 |
| 2023 12 | 40 | 0 | 40 |
| 2023 11 | 45 | 0 | 45 |
| 2023 10 | 63 | 0 | 63 |
| 2023 9 | 33 | 6 | 39 |
| 2023 8 | 37 | 0 | 37 |
| 2023 7 | 41 | 0 | 41 |
| 2023 6 | 36 | 0 | 36 |
| 2023 5 | 52 | 1 | 53 |
| 2023 4 | 30 | 0 | 30 |
| 2023 3 | 12 | 2 | 14 |
| 2023 2 | 11 | 6 | 17 |
| 2023 1 | 12 | 0 | 12 |
| 2022 12 | 2 | 0 | 2 |
| 2021 1 | 1 | 0 | 1 |
| 2020 6 | 1 | 0 | 1 |
| 2020 4 | 0 | 2 | 2 |
| 2020 1 | 1 | 0 | 1 |
| 2019 11 | 2 | 2 | 4 |
Show all
